FUNDING
Vaxess Technologies Awarded NSF and DARPA Funding for Development of mRNA-Based Single-Dose, Refrigeration-Free Vaccine Patch
Vaxess Technologies developers of the MIMIX™ smart release patch, was awarded a grant from the National Science Foundation.
Innodem Neurosciences Receives $6 Mil US Dollars of Financing From Morningside Group
The company reports their mobile software technology is embodied in an application that turns a tablet or a smartphone into a device capable of capturing Eye Movement Biomarkers and Gaze Mapping Biomarkers accurately within minutes in order to assist a clinician's diagnosis.